Outcomes after kidney transplant for a blood vessel condition
Part of Blood & lymphatic, Kidney & urinary clinical trials.
This study looks at outcomes after kidney transplant for a rare blood vessel condition called thrombotic microangiopathy. It aims to learn more about how patients do after transplant at a specific center in Bologna, Italy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have received a kidney transplant (from a living person or someone who has passed away).
- Your transplant could be one kidney, two kidneys, or a kidney along with another organ.
- You are willing to sign a consent form allowing the study to use your medical and genetic information.
- No other criteria that would exclude you are mentioned.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how receiving a kidney transplant changes the health of small blood vessels in the heart. It may help people with advanced kidney disease understand the benefits of transplant on their heart health.
This trial tests a procedure to fix blocked or damaged blood vessels in the pelvis so you can get a kidney transplant. It might help if your blood vessels are the only reason you can't have a transplant yet.
This study looks at how common heart problems and other health conditions affect kidney transplant patients over time. Researchers hope to learn how to better manage these risks.
This trial tests a new approach to help teenagers and young adults keep their first kidney transplant working well. It looks at how to improve long-term success by carefully managing the immune system around the time of transplant.
This study looks at how well kidney transplants work from both living and deceased donors. It may help doctors better understand long-term outcomes for people who get a new kidney.
This study looks at molecular changes in kidney transplants that have microvascular inflammation (a type of injury). It aims to better understand why some transplants get this inflammation, which could lead to better treatments.
Hear when a new Microangiopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.